{{Rsnum
|rsid=10187424
|Chromosome=2
|position=85567174
|Orientation=plus
|GMAF=0.4747
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 45.1 | 32.7
| HCB | 13.1 | 44.5 | 42.3
| JPT | 16.8 | 48.7 | 34.5
| YRI | 54.4 | 34.0 | 11.6
| ASW | 54.4 | 29.8 | 15.8
| CHB | 13.1 | 44.5 | 42.3
| CHD | 12.8 | 39.4 | 47.7
| GIH | 13.9 | 43.6 | 42.6
| LWK | 41.8 | 49.1 | 9.1
| MEX | 19.0 | 43.1 | 37.9
| MKK | 40.4 | 47.4 | 12.2
| TSI | 17.6 | 48.0 | 34.3
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19436136
|Title=Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status
|OA=1
}}

{{PMID Auto GWAS
|PMID=21743467
|Trait=None
|Title=Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|RiskAllele=A
|Pval=3E-15
|OR=1.0900
|ORtxt=[1.06-1.12]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}